| Financial Year |
March 31 2023 |
| Monetary Funds |
125,269,244.19 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
8,251,898.57 |
| Advances to Suppliers |
15,890,553.28 |
| Other Receivables |
7,657,386.71 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
170,557,232.36 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,261,648.76 |
| Total Current Assets |
328,887,963.87 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
68,478,752.41 |
| Fixed Assetes |
238,235,177.38 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
26,084,012.06 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
25,687,427.66 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
441,649,268.84 |
| Total Assets |
770,537,232.71 |
| Short-Term Loans |
400,000,000.00 |
| Trading Financial liabilities |
411,443.43 |
| Notes Payable |
-- |
| Accounts Payable |
63,188,638.39 |
| Accounts Received In Advance |
531,235.70 |
| Employee Compensation Payable |
13,322,121.86 |
| Taxes Payable |
2,463,329.34 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
144,939,807.14 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
16,943,703.76 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
654,589,652.63 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
39,568,957.59 |
| Total Liabilities |
694,158,610.22 |
| Paid-In Capital(Or Share Stock) |
266,634,576.00 |
| Capital Surplus |
184,702,229.87 |
| Surplus Reserve |
29,988,227.52 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-304,696,606.02 |
| Minority Stockholder's Interest |
-124,706,804.88 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
201,085,427.37 |
| Owner's Equity（Stockholder's Equity） |
76,378,622.49 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
770,537,232.71 |
